Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension

被引:33
作者
Minami, J [1 ]
Kawano, Y
Makino, Y
Matsuoka, H
Takishita, S
机构
[1] Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
[2] Natl Cardiovasc Ctr, Div Nephrol & Hypertens, Osaka 5650873, Japan
关键词
ambulatory blood pressure; autonomic function; calcium antagonist; cilnidipine; cold presser; heart rate variability; heart rate;
D O I
10.1046/j.1365-2125.2000.00299.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims The aim of the present study was to evaluate the effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Methods Ten inpatients with mild to moderate essential hypertension (four men and six women; age: 44-64 years) underwent a drug-free period for 7 days and a treatment period with cilnidipine 10 mg orally for another 7 days, in a randomized crossover study. On the sixth day of each period, they underwent autonomic function tests including a mental arithmetic test, a cold presser test and a Valsalva manoeuvre. After these tests, 24 h ambulatory blood pressure, heart rate, and the electrocardiogram R-R intervals were monitored every 30 min. A power spectral analysis of R-R intervals was performed to obtain the low-and high-frequency components. Results Cilnidipine significantly decreased the 24 h blood pressure by 6.5 +/- 1.7 mm Hg systolic (mean+/-s.e.mean; P<0.01) and 5.0+/-1.1 mmHg diastolic (P<0.01), whereas cilnidipine did not change heart rate or any indices of power spectral components. During the cold presser test, the maximum change in systolic blood pressure and percentage changes in both systolic and diastolic blood pressures were significantly lower during the treatment period with cilnidipine than during the drug-free period. The baroreflex sensitivity measured from the overshoot phase of the Valsalva manoeuvre did not differ significantly between the two periods. Conclusions Cilnidipine is effective as a once-daily antihypertensive agent and causes little influence on heart rate and the autonomic nervous system in patients with mild to moderate essential hypertension. Moreover, it is suggested that cilnidipine has an additional clinical benefit in the inhibition of the presser response induced by acute cold stress.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 36 条
[1]  
BREMNER AD, 1993, J HUM HYPERTENS, V7, P79
[2]   INHIBITION OF NORADRENALINE RELEASE BY OMEGA-CONOTOXIN GVIA IN THE RAT TAIL ARTERY [J].
CLASBRUMMEL, B ;
OSSWALD, H ;
ILLES, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (01) :101-110
[3]   Seasonal variation in coronary heart disease in Scotland [J].
Douglas, AS ;
Dunnigan, MG ;
Allan, TM ;
Rawles, JM .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1995, 49 (06) :575-582
[4]   EVIDENCE FOR SYMPATHETIC NEUROTRANSMISSION THROUGH PRESYNAPTIC N-TYPE CALCIUM CHANNELS IN HUMAN SAPHENOUS-VEIN [J].
FABI, F ;
CHIAVARELLI, M ;
ARGIOLAS, L ;
CHIAVARELLI, R ;
DELBASSO, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) :338-342
[5]  
Frank S M, 1994, Clin Auton Res, V4, P257, DOI 10.1007/BF01827431
[6]  
Fujii S, 1997, J PHARMACOL EXP THER, V280, P1184
[7]   NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE [J].
FURBERG, CD ;
PSATY, BM ;
MEYER, JV .
CIRCULATION, 1995, 92 (05) :1326-1331
[8]   Calcium antagonist treatment and cardiovascular responses to a cold pressor test at high altitude [J].
Hanko, E ;
Rostrup, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (3-4) :265-267
[9]   DOMINANT ROLE OF N-TYPE CA-2+ CHANNELS IN EVOKED RELEASE OF NOREPINEPHRINE FROM SYMPATHETIC NEURONS [J].
HIRNING, LD ;
FOX, AP ;
MCCLESKEY, EW ;
OLIVERA, BM ;
THAYER, SA ;
MILLER, RJ ;
TSIEN, RW .
SCIENCE, 1988, 239 (4835) :57-61
[10]   INHIBITORY EFFECT OF CILNIDIPINE ON VASCULAR SYMPATHETIC NEUROTRANSMISSION AND SUBSEQUENT VASOCONSTRICTION IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
HOSONO, M ;
FUJII, S ;
HIRUMA, T ;
WATANABE, K ;
HAYASHI, Y ;
OHNISHI, H ;
TAKATA, Y ;
KATO, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1995, 69 (02) :127-134